Document is current
Any future updates will be listed below
-
Authors
Wang, Jialiang S. https://orcid.org/0000-0002-3409-7619
Strauss, Katelyn
Houghton, Caroline
Islam, Numa
Yoon, Sung-Hee
Kobayashi, Tatsuya
Brooks, Daniel J.
Bouxsein, Mary L.
Zhao, Yingshe
Yee, Cristal S.
Alliston, Tamara N. https://orcid.org/0000-0001-9992-2897
Wein, Marc N. https://orcid.org/0000-0002-6015-8147
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (K99AR081897, R00AR081897, P30AR066261, P30AR075042)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (P01DK011794, R01DK116716)
- License Information
-
More Information
Article History
Received: 8 August 2024
Revised: 15 April 2025
Accepted: 27 April 2025
First Online: 19 July 2025
Competing interests
: The authors declare competing interest. M.N.W. has received research funding from Radius Health and is a co-inventor on pending patents regarding the use of SIK inhibitors for osteoporosis. M.N.W. serves as a consultant for Relation Therapeutics, Sitryx Therapeutics, Aditum Bio, and GLG.
